The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2020
DOI: 10.1016/j.msec.2020.110999
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(10 citation statements)
references
References 55 publications
1
8
0
Order By: Relevance
“…However, the shift was more accentuated for the 12HSA organogels. The melting temperature (Tmelt) for the 12HSA organogels without VE was close to 79 °C, as reported by Esposito and coworkers [ 38 ] at the same concentration, but higher than 37 °C for the gelation temperature (Tgel). Besides the different rheometer geometries and oily phases, the authors used strategies that could impact the crystallization pattern, such as a slower cooling rate compared to in our experiment (1 °C/min), a surfactant, and a co-solvent [ 3 , 37 ].…”
Section: Resultssupporting
confidence: 83%
“…However, the shift was more accentuated for the 12HSA organogels. The melting temperature (Tmelt) for the 12HSA organogels without VE was close to 79 °C, as reported by Esposito and coworkers [ 38 ] at the same concentration, but higher than 37 °C for the gelation temperature (Tgel). Besides the different rheometer geometries and oily phases, the authors used strategies that could impact the crystallization pattern, such as a slower cooling rate compared to in our experiment (1 °C/min), a surfactant, and a co-solvent [ 3 , 37 ].…”
Section: Resultssupporting
confidence: 83%
“…Nevertheless, it was shown that 12‐HSA oleogels could be a promising tool for the controlled release of neutraceuticals in tablets [ 104 ] or even injectable implants. [ 105 ]…”
Section: Othersmentioning
confidence: 99%
“…However, the disadvantages of these polymers include their degradation to highly acidic monomers, which might trigger autocatalytic processes [ 13 , 14 , 15 ], drug degradation [ 16 ], or drug precipitation [ 17 ] prior to release due to the formation of highly acidic microenvironments [ 13 ] inside the polymer matrix. Solid lipids [ 18 , 19 ], organogels [ 20 , 21 , 22 ], and phospholipids [ 23 , 24 ] are biodegradable and biocompatible alternatives to PLGA and PLA, which deserve further investigation.…”
Section: Introductionmentioning
confidence: 99%